Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
(viii) suppression of de novo lipogenesis after decreasing fatty acid synthase and acetyl-CoA carboxylase 1 expression and (ix) reduction of insulin/glucagon ratio that results in almost 25% restriction of glucose utilization and enhanced ketogenesis
From a public health perspective, these transformations are beneficial for weight loss, blood sugar control and cardiovascular outcomes
It is comparable in magnitude to what happens when you drink a large cup of coffee or walk up a flight of stairs
Product Attributes CAS # : 218949-48-5 (Tesamorelin) / 170851-70-4 (Ipamorelin) Molecular Formula : C221H366N72O67S (Tesamorelin) / C38H49N9O5 (Ipamorelin) Sequence (AA) : YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 (Tesamorelin) / Aib-His-D-2-Nal-D-Phe-Lys-NH2 (Ipamorelin) Molecular Weight : ~5196 g/mol (Tesamorelin) / ~711.9 g/mol (Ipamorelin) PubChem CID : 16137828 (Tesamorelin) / 9831659 (Ipamorelin) Half-Life : ~26-38 minutes (Tesamorelin) / ~2 hours (Ipamorelin) Synonyms : TH9507, Egrifta (Tesamorelin)
A 2019 systematic review in Hepatology found that choline supplementation reduced liver fat by 812% over 12 weeks in NAFLD patients, but no significant weight loss occurred
